CoChat

Osteoarthritis — an untreatable disease?

The DOI matches its Crossref record; 123 of the 124 references it cites were found in a registry or an index.

Abstract

Osteoarthritis is a painful and disabling disease that affects millions of patients. Its aetiology is largely unknown, but is most likely multi-factorial. Osteoarthritis poses a dilemma: it often begins attacking different joint tissues long before middle age, but cannot be diagnosed until it becomes symptomatic decades later, at which point structural alterations are already quite advanced. In this review, osteoarthritis is considered as a disease of the whole joint that may result from multiple pathophysiological mechanisms, one of which is the dysregulation of lipid homeostasis. No proven disease-modifying therapy exists for osteoarthritis and current treatment options for chronic osteoarthritic pain are insufficient, but new pharmacotherapeutic options are emerging.

Overview

Integrity signals

Registry

Crossref · 10.1038/nrd1693

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 123 references

Research works printed but not linked: 6

  1. Harris, E. D. Jr. The Bone and Joint decade: a catalyst for progress. Arthritis Rheum 44, 1969–1970 (2004). · doi:10.1002/1529-0131(200109)44:9<1969::aid-art342>3.0.co;2-a
  2. Brandt, K. D., Smith, G. N. Jr & Simon, L. S. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum. 43, 1192–1203 (2000). · doi:10.1002/1529-0131(200006)43:6<1192::aid-anr2>3.0.co;2-l
  3. Bingham, C. et al. Clinically significant placebo improvement occurs by 6 months and is maintained through 24 months in a study of knee OA pain and function. Osteoarthr. Cartil. 12, S132 Abs. P323 (2004).
  4. Flechtenmacher, J. et al. Bradykinin-receptor-inhibition — a therapeutic option in osteoarthritis? Osteoarthr. Cartil. 12, S137 Abs. P332 (2004).
  5. Ding, C & Cicuttini, F. Licofelone (Merckle). IDrugs 6, 802–808 (2003).
  6. Schnitzer, T. J., Kivitz, A. J., Lipetz, S., Sanders, N. & Hee, A. A Phase II study of the efficacy and safety of AZD3582, a CINOD, in subjects with osteoarthritis of the knee. Eur. League Against Rheumatism 2004 Conference Abs OP0016 [online], < http://mcic3.textor.com/cgi-bin/mc/printabs.pl?APP=eular2004SCIE-abstract&TEMPLATE=&keyf=0094&showHide=show&client= > (2004)

Cited by

Items 301–400 of 592

Metadata

Authors
Wieland, H. A., Michaelis, M., Kirschbaum, B. J., & Rudolphi, K. A.
Affiliations
Sanofi (Germany) (DE)
Corresponding author
Wieland, Heike A.
Venue
Nature Reviews Drug Discovery
Published
2005-04
Volume
4
Issue
4
Pages
331-344
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W1487036716
Cited by
585
References
124
Citations by year
2026: 34 · 2025: 32 · 2024: 44 · 2023: 31 · 2022: 36 · 2021: 34 · 2020: 25 · 2019: 36 · 2018: 24 · 2017: 31 · 2016: 26 · 2015: 29 · 2014: 29 · 2013: 32 · 2012: 29
FWCI
3.52
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Reviews Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
Funders
Sanofi
Topics
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacological Effects of Medicinal Plants
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Keywords
osteoarthritis, disease-modifying therapy, early-onset osteoarthritis, pharmacotherapy, treatment options
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal, Humans, Osteoarthritis, Pain, Drug Design, Molecular Structure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.